APA (7th ed.) Citation

Kwon, J. S., Jang, J. H., Kang, D., Yoo, S. Y., Kim, Y. K., & Cho, S. (2009). Long‐term efficacy and safety of aripiprazole in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder: 26‐week prospective study. Psychiatry and clinical neurosciences, 63(1), 73-81. https://doi.org/10.1111/j.1440-1819.2008.01907.x

Chicago Style (17th ed.) Citation

Kwon, Jun Soo, Joon Hwan Jang, Do‐Hyung Kang, So Young Yoo, Yong Ku Kim, and Seong‐Jin Cho. "Long‐term Efficacy and Safety of Aripiprazole in Patients with Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder: 26‐week Prospective Study." Psychiatry and Clinical Neurosciences 63, no. 1 (2009): 73-81. https://doi.org/10.1111/j.1440-1819.2008.01907.x.

MLA (9th ed.) Citation

Kwon, Jun Soo, et al. "Long‐term Efficacy and Safety of Aripiprazole in Patients with Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder: 26‐week Prospective Study." Psychiatry and Clinical Neurosciences, vol. 63, no. 1, 2009, pp. 73-81, https://doi.org/10.1111/j.1440-1819.2008.01907.x.